skip to Main Content

Non-regulatory Press releases

PILA PHARMA AB, a Swedish biotech company, announces adjustment to the management team to prepare for coming upscaling of the company.

Malmö, Sweden, May 21, 2021 Download the press release as PDF here “I am pleased to share the information that we have promoted Lars Bukhave Rasmussen, to become Chief Operating Officer (COO).  Further, I’m proud to announce the appointment of Elna Lembrér Åström, to new Chief Financial Officer (CFO)”, says CEO Dorte X. Gram.  Lars Bukhave Rasmussen joined PILA PHARMA in…

Read more

PILA PHARMA announces successful completion of Pre-IPO

Malmö, Sweden, 10 March 2021 Download the press release as PDF here PILA PHARMA AB, a Swedish biotech company, today, announces the successful completion of a recent new shares issue (Pre-IPO).  “I am very happy to share the information that we have successfully raised the 15 MSEK that we set out to do and previously communicated we would”, says CEO…

Read more

PILA PHARMA announces plans for an IPO in Q2-2021

Malmö, Sweden, 17h November 2020 Download the press release as PDF here PILA PHARMA AB, a Swedish biotech company, is pleased to announce the decision to list the company. The Initial Public Offering (IPO), aiming for listing of the company’s shares on one of the unregulated stock exchanges in Sweden, is targeted for Q2-2021.To facilitate the IPO process, Göteborg Corporate…

Read more

2018, 11, 07 — PILA PHARMA Press Release

Malmö, Sweden, 7th November 2018 You can also download the press release as PDF here PILA PHARMA announces good safety of XEN-D0501 following single doses in patients with type 2 diabetes PILA PHARMA AB, a pharmaceutical company based in Malmö, Sweden, is pleased to announce that on November 1st, 2018, the dosing of patients in its first trial PP-CT01, studying…

Read more

Contact us

Back To Top
Search